<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02681458</url>
  </required_header>
  <id_info>
    <org_study_id>IslamicAUM</org_study_id>
    <nct_id>NCT02681458</nct_id>
  </id_info>
  <brief_title>Superficial and Cutaneous Fungal Infections Among Drug-users in Northeast Region of Iran</brief_title>
  <official_title>The Comparison of Dermatophytosis and Other Fungal Infections Between Drug Users and Non Drug Users</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Islamic Azad University of Mashhad</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Islamic Azad University of Mashhad</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was about survey of prevalence of fungal infections among drug
      users referring to methadone wards of Hospitals in northeast region of Iran
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There were two groups with overall members of 1436. Statistically, the investigators have
      used &quot;Likelihood ratio &quot; and &quot; Exact's Fisher&quot; tests.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Actual">April 2014</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The Prevalence of Superficial and Cutaneous Fungal Infections Among Drug and Non-Drug Users</measure>
    <time_frame>up to two months</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">1436</enrollment>
  <condition>Skin and Subcutaneous Tissue Fungal Infections</condition>
  <arm_group>
    <arm_group_label>Drug Users</arm_group_label>
    <description>Case group that consisted of drug users with fungal infections</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-drug Users</arm_group_label>
    <description>Control group that consisted of non drug users with fungal infections</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Direct Examination</intervention_name>
    <description>It was an observational study and subjects received their routine treatment.</description>
    <arm_group_label>Drug Users</arm_group_label>
    <arm_group_label>Non-drug Users</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      hair, nail, cutaneous lesions
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        people from northeast region of Iran referring to Methadone clinics. there were no
        limitations of age and sex.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Suspected fungal lesions

        Exclusion Criteria:

          -  non use of local or edible anti-fungal drugs and not taking bath within the last 48
             hours of testing
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hassan Yazdanfar, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>assistant professor of mycology and parasitology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Islamic Azad University of Mashhad</name>
      <address>
        <city>Mashhad</city>
        <state>Khorasan razavi</state>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 31, 2016</study_first_submitted>
  <study_first_submitted_qc>February 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 12, 2016</study_first_posted>
  <results_first_submitted>March 15, 2016</results_first_submitted>
  <results_first_submitted_qc>April 13, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 20, 2016</results_first_posted>
  <last_update_submitted>April 13, 2016</last_update_submitted>
  <last_update_submitted_qc>April 13, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Islamic Azad University of Mashhad</investigator_affiliation>
    <investigator_full_name>Hassan Yazdanfar</investigator_full_name>
    <investigator_title>Head of parasitology and mycology department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Mycoses</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>The investigators have not decided about this issue yet</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Drug Users</title>
          <description>Case group that consisted of drug users with fungal infections
Direct Examination: It was an observational study and subjects received their routine treatment.</description>
        </group>
        <group group_id="P2">
          <title>Non-drug Users</title>
          <description>Control group that consisted of non-drug users with fungal infections
Direct Examination: It was an observational study and subjects received their routine treatment.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="718"/>
                <participants group_id="P2" count="718"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="73"/>
                <participants group_id="P2" count="62"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="645"/>
                <participants group_id="P2" count="656"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Drug Users</title>
          <description>Case group that consisted of drug users with fungal infections
Direct Examination: It was an observational study and subjects received their routine treatment.</description>
        </group>
        <group group_id="B2">
          <title>Non-drug Users</title>
          <description>Control group that consisted of non drug users with fungal infections
Direct Examination: It was an observational study and subjects received their routine treatment.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="718"/>
            <count group_id="B2" value="718"/>
            <count group_id="B3" value="1436"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38.3" lower_limit="9" upper_limit="90"/>
                    <measurement group_id="B2" value="36.8" lower_limit="11" upper_limit="86"/>
                    <measurement group_id="B3" value="37.55" lower_limit="9" upper_limit="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="116"/>
                    <measurement group_id="B2" value="137"/>
                    <measurement group_id="B3" value="253"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="602"/>
                    <measurement group_id="B2" value="581"/>
                    <measurement group_id="B3" value="1183"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Iran, Islamic Republic of</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="718"/>
                    <measurement group_id="B2" value="718"/>
                    <measurement group_id="B3" value="1436"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>The Prevalence of Superficial and Cutaneous Fungal Infections Among Drug and Non-Drug Users</title>
        <time_frame>up to two months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Drug Users</title>
            <description>Case group that consisted of drug users with fungal infections
Direct Examination: It was an observational study and subjects received their routine treatment.</description>
          </group>
          <group group_id="O2">
            <title>Non-drug Users</title>
            <description>Control group that consisted of non-drug users with fungal infections
Direct Examination: It was an observational study and subjects received their routine treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>The Prevalence of Superficial and Cutaneous Fungal Infections Among Drug and Non-Drug Users</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="718"/>
                <count group_id="O2" value="718"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73"/>
                    <measurement group_id="O2" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>Serious and Other Adverse Events were not collected</desc>
      <group_list>
        <group group_id="E1">
          <title>Drug Users</title>
          <description>Case group that consisted of drug users with fungal infections
Direct Examination: It was an observational study and subjects received their routine treatment.</description>
        </group>
        <group group_id="E2">
          <title>Non-drug Users</title>
          <description>Control group that consisted of non-drug users with fungal infections
Direct Examination: It was an observational study and subjects received their routine treatment.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Hassan Yazdanfar</name_or_title>
      <organization>Islamic Azad University of Mashhad</organization>
      <phone>00985136631004</phone>
      <email>hasanyazdanfar@yahoo.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

